Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tom S Chang

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Ophthalmology Clinics of North America|November 10, 2004
Anterior segment complications associated with scleral bucklingAlexander Charonis, Tom S Chang
Ophthalmology|December 7, 2007
Sutureless 25-gauge vitrectomy: risky or rewarding?Adam Martidis, Tom S Chang
Retina (Philadelphia, Pa.)|March 9, 2002
Posterior retinal vasculitis associated with multiple sclerosisPaul J Mackenzie, Tom S Chang, Dawn Hay
Ophthalmology|August 5, 2009
Perfused, but not leakingJonathan L Prenner, Richard Kaiser, Tom S Chang
Retina (Philadelphia, Pa.)|February 10, 2006
Diagnostic and therapeutic challengesEdward Chaum, Amani Fawzi, Tom S Chang, et al.
American Journal of Ophthalmology|December 31, 2002
Limited macular translocation for the management of subfoveal choroidal neovascularization after photodynamic therapyGildo Y Fujii, Eugene de Juan, Mark S Humayun, et al.
Current Opinion in Ophthalmology|March 28, 2012
Stem cell therapy for retinal diseaseMichael D Tibbetts, Michael A Samuel, Tom S Chang, et al.
Ophthalmology|October 3, 2002
Validity of the SF-12 quality of life instrument in patients with retinal diseasesDenise R Globe, Stanislav Levin, Tom S Chang, et al.
Retina (Philadelphia, Pa.)|November 26, 2009
Short-term effectiveness of intravitreal bevacizumab versus ranibizumab injections for patients with neovascular age-related macular degenerationTom S Chang, Gregg Kokame, Raynor Casey, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|January 14, 2009
Improved vision-related function after ranibizumab vs photodynamic therapy: a randomized clinical trialNeil M Bressler, Tom S Chang, Jennifer T Fine, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Ophthalmology Clinics of North America|November 10, 2004
Anterior segment complications associated with scleral bucklingAlexander Charonis, Tom S Chang
Ophthalmology|December 7, 2007
Sutureless 25-gauge vitrectomy: risky or rewarding?Adam Martidis, Tom S Chang
Retina (Philadelphia, Pa.)|March 9, 2002
Posterior retinal vasculitis associated with multiple sclerosisPaul J Mackenzie, Tom S Chang, Dawn Hay
Ophthalmology|August 5, 2009
Perfused, but not leakingJonathan L Prenner, Richard Kaiser, Tom S Chang
Retina (Philadelphia, Pa.)|February 10, 2006
Diagnostic and therapeutic challengesEdward Chaum, Amani Fawzi, Tom S Chang, et al.
American Journal of Ophthalmology|December 31, 2002
Limited macular translocation for the management of subfoveal choroidal neovascularization after photodynamic therapyGildo Y Fujii, Eugene de Juan, Mark S Humayun, et al.
Current Opinion in Ophthalmology|March 28, 2012
Stem cell therapy for retinal diseaseMichael D Tibbetts, Michael A Samuel, Tom S Chang, et al.
Ophthalmology|October 3, 2002
Validity of the SF-12 quality of life instrument in patients with retinal diseasesDenise R Globe, Stanislav Levin, Tom S Chang, et al.
Retina (Philadelphia, Pa.)|November 26, 2009
Short-term effectiveness of intravitreal bevacizumab versus ranibizumab injections for patients with neovascular age-related macular degenerationTom S Chang, Gregg Kokame, Raynor Casey, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|January 14, 2009
Improved vision-related function after ranibizumab vs photodynamic therapy: a randomized clinical trialNeil M Bressler, Tom S Chang, Jennifer T Fine, et al.
Pageof 3